Detail
LncRNA Name | BLACAT1 |
Synonyms | BLACAT1, LINC00912, UBC1, onco-lncRNA-30, linc-UBC1, onco-lncRNA-30 |
Region | GRCh38_1:205434886-205437879 Sequence |
Ensembl | ENSG00000281406 |
RefSeq | NR_103783 |
Circulating | ✘ |
Drug-resisitant | ✔ |
Prognostic | ✘ |
MiRNA | ✔ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | qPCR, Western blot, Luciferase reporter assay, in vitro knockdown etc. |
Sample | cell lines (BGC-823, SGC-7901, MGC-803,GES-1),gastric cancer tissue |
Expression Pattern | up-regulated |
Function Description | In vitro, BLACAT1 knockdown decreased the expression levels of drug resistance related genes and ABCB1 protein. BLACAT1 knockdown significantly promoted apoptosis and down-regulated the invasion and the IC50 value of oxaliplatin.In vivo, BLACAT1 knockdown suppressed the tumor growth of gastric cancer cells. Bioinformatics tools and luciferase assay indicated that miR-361 both targeted 3'-UTR of BLACAT1 and ABCB1mRNA, suggesting the BLACAT1/miR-361/ABCB1 regulatory pathway. |
Pubmed ID | 29710482 |
Year | 2018 |
Title | Long noncoding RNA BLACAT1 modulates ABCB1 to promote oxaliplatin resistance of gastric cancer via sponging miR-361. |
External Links |
Links for BLACAT1 | GenBank HGNC lncrnadb Noncode |
Links for gastric cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.